EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mitochondria, a Key Target in Amyotrophic Lateral Sclerosis Pathogenesis

Emmanuelle C Genin iD, Mélanie Abou-Ali, Véronique Paquis-Flucklinger

Genes · 24.10.2023 · 14 (11) · 1981

DOI: 10.3390/genes14111981 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 24.10.2023. Verfasst von Emmanuelle C Genin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Research on Cancer and Aging, Nice (IRCAN), Université Côte d'Azur, Inserm U1081, CNRS UMR7284, Centre Hospitalier Universitaire (CHU) …. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 277 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agence Nationale de la Recherche, Fondation pour la Recherche Médicale.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondrial dysfunction occurs in numerous neurodegenerative diseases, particularly amyotrophic lateral sclerosis (ALS), where it contributes to motor neuron (MN) death. Of all the factors involved in ALS, mitochondria have been considered as a major player, as secondary mitochondrial dysfunction has been found in various models and patients. Abnormal mitochondrial morphology, defects in mitochondrial dynamics, altered activities of respiratory chain enzymes and increased production of reactive oxygen species have been described. Moreover, the identification of CHCHD10 variants in ALS patients was the first genetic evidence that a mitochondrial defect may be a primary cause of MN damage and directly links mitochondrial dysfunction to the pathogenesis of ALS. In this review, we focus on the role of mitochondria in ALS and highlight the pathogenic variants of ALS genes associated with impaired mitochondrial functions. The multiple pathways demonstrated in ALS pathogenesis suggest that all converge to a common endpoint leading to MN loss. This may explain the disappointing results obtained with treatments targeting a single pathological process. Fighting against mitochondrial dysfunction appears to be a promising avenue for developing combined therapies in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyotrophic Lateral SclerosisHumansMitochondriaMotor NeuronsCell DeathMitochondrial Proteins

Stichwörter der Autor:innen

ALS genesCHCHD10amyotrophic lateral sclerosisfrontotemporal dementiamitochondriamotor neuron disease

Substanzen

CHCHD10 protein, humanMitochondrial Proteins

Autor:innen und Institutionen

  • Institute for Research on Cancer and Aging, Nice (IRCAN), Université Côte d'Azur, Inserm U1081, CNRS UMR7284, Centre Hospitalier Universitaire (CHU) de Nice, 06200 Nice, France.

ORCID-Profile: Emmanuelle C Genin

Förderung

  • Agence Nationale de la Recherche
  • Fondation pour la Recherche Médicale

Zitieren

APA

Genin, E. C., Abou-Ali, M., & Paquis-Flucklinger, V. (2023). Mitochondria, a Key Target in Amyotrophic Lateral Sclerosis Pathogenesis. Genes, 14(11), 1981. https://doi.org/10.3390/genes14111981

Vancouver

Genin EC, Abou-Ali M, Paquis-Flucklinger V. Mitochondria, a Key Target in Amyotrophic Lateral Sclerosis Pathogenesis. Genes. 2023;14(11):1981. doi:10.3390/genes14111981

BibTeX
@article{Genin2023,
  author = {Genin, Emmanuelle C and Abou-Ali, Mélanie and Paquis-Flucklinger, Véronique},
  title = {Mitochondria, a Key Target in Amyotrophic Lateral Sclerosis Pathogenesis},
  journal = {Genes},
  year = {2023},
  volume = {14},
  number = {11},
  pages = {1981},
  doi = {10.3390/genes14111981}
}
Kostenlos starten →